Open AccessAssociation of Serum Ferritin Levels with Metabolic Syndrome and Insulin Resistance
Author(s) -
Meghana K Padwal,
Mohsin Murshid,
Prachee Nirmale,
Rajani Melinkeri
Publication year - 2015
Publication title -
journal of clinical and diagnostic research
Language(s) - English
Resource type - Journals
eISSN - 2249-782X
pISSN - 0973-709X
DOI - 10.7860/jcdr/2015/13480.6564
Subject(s) - insulin resistance , ferritin , metabolic syndrome , medicine , endocrinology , insulin , biomarker , homeostatic model assessment , diabetes mellitus , biology , biochemistry
The impact of CVDs and Type II DM is increasing over the last decade. It has been estimated that by 2025 their incidence will double. Ferritin is one of the key proteins regulating iron homeostasis and is a widely available clinical biomarker of iron status. Some studies suggest that prevalence of atherosclerosis and insulin resistance increases significantly with increasing serum ferritin. Metabolic syndrome is known to be associated with increased risk of atherosclerosis as well as insulin resistance.